Seeking Safety Group Therapy for Co-Occurring Substance Use Disorder and PTSD among Transgender Women Living with HIV: A Pilot Study

2017 ◽  
Vol 49 (4) ◽  
pp. 344-351 ◽  
Author(s):  
Susannah Empson ◽  
Yvette P. Cuca ◽  
Jennifer Cocohoba ◽  
Carol Dawson-Rose ◽  
Katy Davis ◽  
...  
2021 ◽  
Vol 6 (2) ◽  

Background: HIV and substance use disorder are major risk factors for poor obstetric outcomes and women who live with both conditions should be closely monitored during pregnancy and postpartum. It is unclear what engagement in obstetric care for women living with HIV and substance use disorder look like before and during the COVID-19 pandemic. This literature review aims to examine engagement in obstetric care for women living with HIV and substance use disorder before and during the COVID-19 pandemic and offer strategies to increase engagement in care during the COVID-19 pandemic for this vulnerable population. Methods: A literature review was conducted on January 12, 2021 across major databases including Pubmed, PsychInfo, Cochrane, and CINAHL. Results: A total of 6 studies were included in this review. Studies either assessed outcome of engagement in care among pregnant women living with HIV or pregnant women with substance use disorder. Our findings demonstrate that pregnant women with HIV or substance use disorder tend to have comorbid conditions and are less likely to be engaged in obstetric care, and this trend is aggravated by the COVID-19 pandemic. Approaches to care during the COVID-19 pandemic included expanding services outside of the clinic to virtual visits, telephonic engagement, text messaging, or electronic mail. Conclusion: Pregnant women with HIV and/or substance use disorder are at much higher risk for poor engagement in obstetric care, suboptimal financial and social support, and adverse outcomes. We recommend each in-person clinic visit be accompanied by thorough screening for mental health issues, and psychosocial difficulties. Referral services should be ready and accessible if the woman screens positive. Nurses are an integral part of ensuring proper care coordination and follow-up. More research is needed to examine engagement in obstetric care for women with both HIV and substance use disorder during the COVID-19 pandemic.


2017 ◽  
Vol 23 (5) ◽  
pp. 260-268 ◽  
Author(s):  
Ilse N. Beaufort ◽  
Gerdien H. De Weert-Van Oene ◽  
Victor A.J. Buwalda ◽  
J. Rob J. de Leeuw ◽  
Anna E. Goudriaan

2020 ◽  
Vol 4 (2) ◽  
pp. 140-148
Author(s):  
Kennedy M Ngowi ◽  
Eusebious Maro ◽  
Rob E Aarnoutse ◽  
Blandina T Mmbaga ◽  
Mirjam A. G Sprangers ◽  
...  

Background: Pregnant and breastfeeding Women Living with HIV (WLHIV) often have difficulties in reaching adequate levels of adherence (>95%) to Antiretroviral treatment. “Forgetting” is the most commonly mentioned reason. Sending reminders via SMS is expected to improve adherence. We conducted a pilot study to investigate acceptability, user experience and technical feasibility of sending reminder-SMS to WLHIV. Methods: This was a 6-months observational pilot-study among WLHIV attending antenatal and postnatal care at Kilimanjaro Christian Medical Centre in Moshi, Tanzania. Women received a reminder-SMS 30 minutes before usual time of intake. One hour later, they received an SMS asking whether they took medication to which they could reply with ‘Yes’ or ‘No’. Messages were sent 3 times a week on randomly chosen days to prevent reliance on daily messages. We calculated the percentage of number of SMS delivered, failed to be delivered, and replied to. We analysed feedback from exit-interviews about experience with the SMS-reminders. Results: 25 women were enrolled (age 18-45), 2 were lost to follow up. 5,054 messages were sent of which 53 failed to be delivered (1%). 1,880 SMS were sent with a question if medication was taken; 1,012 (54%) messages were replied to, of which 1,003 (99%) were replied with ‘YES’ and closely to ‘YES’, and a total of 9 (1%) with ‘NO’ and ‘closely to NO’. 868 messages (46%) were not responded to due to either dropout, change of phone number, loss of phone or network failure. Results from 18 interviews showed that 16 (89%) women were satisfied with SMS reminders. 2 (11%) were concerned about unwanted disclosure because of the content ‘don’t forget to take medication’ and one reported other privacy issues (6%). 3 (17%) women experienced stigma. Conclusion: 99%of SMS being delivered indicates that SMS reminders in this resource-limited setting are technically feasible. However, concerns regarding privacy were noted, specifically the risk of unwanted disclosure and the experience of stigma. Participants indicated that being made aware of their adherence, motivated them to adhere better. However, personalised and more neutral content of the SMS might be a way to improving the intervention.


2018 ◽  
Vol 53 (11) ◽  
pp. 1788-1800 ◽  
Author(s):  
Lisa M. Najavits ◽  
Karen Krinsley ◽  
Molly E. Waring ◽  
Matthew W. Gallagher ◽  
Christopher Skidmore

2021 ◽  
Author(s):  
Melinda Brown ◽  
May Maloba ◽  
Catherine Wexler ◽  
Natabhona Mabachi ◽  
Sharon Koech ◽  
...  

BACKGROUND Evidence that text messages can support patient adherence to HIV care is growing. We conducted a pilot study of the HIV Infant Tracking System (HITSystem 2.0), an intervention that includes SMS to patients to support maternal medication adherence, appointment attendance, and hospital-based deliveries during the antenatal period. OBJECTIVE The objective of this study was to qualitatively assess women’s experiences receiving SMS to understand message utility and acceptability with the goal of refining and strengthening the intervention. METHODS As part of an intervention development pilot study, we conducted semi-structured interviews with 33 women living with HIV who received SMS through the HITSystem 2.0 throughout their pregnancy and postpartum period. Interview questions assessed women’s feedback of the SMS, the impact of the SMS on their PMTCT care, and suggestions for improvement. RESULTS Participants described how SMS reinforced existing strategies for medication adherence and served as cues to action for antenatal appointments and hospital-based deliveries. SMS also provided encouragement and enhanced their sense of engagement with their clinical care team. Given the neutral content of the messages, most women reported no concerns about message confidentiality. Recommendations to enhance utility included greater customizability (timing and frequency of messages) and a few women suggested more comprehensive counseling regarding the SMS content to anticipate at the time of enrollment. CONCLUSIONS SMS content was deemed useful and acceptable by pregnant and postpartum women living with HIV and engaged in PMTCT services. Participant recommendations to increase message customization options have been adopted to enhance the intervention. CLINICALTRIAL Trial registration: clinicaltrials.gov, NCT02726607. Registered 01 April 2016. Retrospectively registered. https://clinicaltrials.gov/ct2/show/NCT02726607


2020 ◽  
Vol 36 (5) ◽  
pp. 406-414
Author(s):  
Nathan A. Summers ◽  
Jonathan A. Colasanti ◽  
Daniel J. Feaster ◽  
Wendy S. Armstrong ◽  
Allan Rodriguez ◽  
...  

AIDS Care ◽  
2020 ◽  
Vol 32 (8) ◽  
pp. 1008-1013
Author(s):  
Ashley Lacombe-Duncan ◽  
Carmen H. Logie ◽  
Peter A. Newman ◽  
Greta R. Bauer ◽  
Mina Kazemi

Sign in / Sign up

Export Citation Format

Share Document